Legal Representation
Attorney
Jeannine Rittenhouse
USPTO Deadlines
Next Deadline
192 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
January 16, 2026
Extension Available
Until July 16, 2025
Application History
23 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 26, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Jun 26, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 26, 2025 | EXT2 | S | SOU EXTENSION 2 FILED |
| Mar 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 15, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Jan 14, 2025 | EXT1 | S | SOU EXTENSION 1 FILED |
| Jan 14, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jul 16, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 21, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 21, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 1, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 15, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 15, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Apr 15, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Apr 15, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Apr 15, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Mar 28, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 28, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Mar 28, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Mar 27, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Aug 1, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jul 29, 2023 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment, diagnosis, prevention and control of infectious diseases in food producing animals and livestock; veterinary preparations for enhancing reproduction in livestock; immunorestorative biopharmaceuticals for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; animal feed additives for use as nutritional supplements; veterinary preparations or animal feed additives for use in decreasing gas emissions from animals, animal carcasses, or animal waste; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; veterinary hormone preparations and hormone preparations in the nature of biological implants for animals, namely, progesterone, estrogen and testosterone; veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat; veterinary preparations for companion animals, namely, to treat and prevent parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders; veterinary preparations for companion animals for nonsurgical sterilization, namely, hormones for the control and prevention of reproductive functions; veterinary preparations for treating and preventing fleas, ticks, lice, flies, and mosquitos on companion animals; veterinary preparations, namely, vaccines for companion animals including horses; veterinary preparations to control diseases and parasites in fish
Classification
International Classes
005